Edition:
United Kingdom

Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

46.65USD
25 Sep 2018
Change (% chg)

-- (--)
Prev Close
$46.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
255,120
52-wk High
$50.43
52-wk Low
$27.23

Chart for

About

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is... (more)

Overall

Beta: 0.26
Market Cap(Mil.): $2,541.79
Shares Outstanding(Mil.): 68.44
Dividend: --
Yield (%): --

Financials

  MYGN.OQ Industry Sector
P/E (TTM): 118.25 148.68 32.76
EPS (TTM): 0.31 -- --
ROI: 2.38 9.38 14.61
ROE: 2.84 14.71 16.33

BRIEF-Myriad Genetics Reports Q3 GAAP Earnings Per Share $0.16

* MYRIAD GENETICS REPORTS FISCAL THIRD-QUARTER 2018 FINANCIAL RESULTS

08 May 2018

BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan

April 2 Myriad Genetics Inc - ‍Astrazeneca And Merck Are Seeking Approval Of Lynparza In Japan For Treating Patients With Brca :

02 Apr 2018

Earnings vs. Estimates